Cadonilimab Combined With Stereotactic Radiotherapy as Second-line Treatment for Brain Metastases

Clinical trial NCT06702826 · RECRUITING

Trial details

NCT number: NCT06702826
Sponsor: Rongrong Zhou
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Brain Metastases Stereotactic Radiation Immunotherapy

Start date: 2024-11-01
Primary completion: 2027-11-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.